Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies.
Takahashi M, Ai T, Sinozuka K, Baba Y, Igawa G, Nojiri S, Yamamoto T, Yuri M, Takei S, Saito K, Horiuchi Y, Kanno T, Tobiume M, Khasawneh A, Paran FJ, Hiki M, Wakita M, Miida T, Suzuki T, Okuzawa A, Takahashi K, Naito T, Tabe Y. Takahashi M, et al. Among authors: wakita m. Sci Rep. 2022 Sep 1;12(1):14909. doi: 10.1038/s41598-022-19073-z. Sci Rep. 2022. PMID: 36050347 Free PMC article.
Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests.
Wakita M, Idei M, Saito K, Horiuchi Y, Yamatani K, Ishikawa S, Yamamoto T, Igawa G, Hinata M, Kadota K, Kurosawa T, Takahashi S, Saito T, Misawa S, Akazawa C, Naito T, Miida T, Takahashi K, Ai T, Tabe Y. Wakita M, et al. PLoS One. 2021 Feb 8;16(2):e0246536. doi: 10.1371/journal.pone.0246536. eCollection 2021. PLoS One. 2021. PMID: 33556086 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
Hiki M, Tabe Y, Ai T, Matsue Y, Harada N, Sugimoto K, Matsushita Y, Matsushita M, Wakita M, Misawa S, Idei M, Miida T, Tamura N, Takahashi K, Naito T. Hiki M, et al. Among authors: wakita m. PLoS One. 2021 Apr 6;16(4):e0249449. doi: 10.1371/journal.pone.0249449. eCollection 2021. PLoS One. 2021. PMID: 33822809 Free PMC article. Clinical Trial.
SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo.
Fukuda H, Seyama K, Ito K, Ai T, Nojiri S, Hori S, Wakita M, Saito K, Shida Y, Nagura R, Hasegawa M, Kanemoto C, Tokuhara M, Okajima K, Yoshikawa Y, Katsuta N, Yamamoto T, Idei M, Horiuchi Y, Yamatani K, Misawa S, Naito T, Miida T, Sato H, Hattori N, Tabe Y, Takahashi K. Fukuda H, et al. Among authors: wakita m. Sci Rep. 2021 Apr 16;11(1):8380. doi: 10.1038/s41598-021-87688-9. Sci Rep. 2021. PMID: 33863960 Free PMC article.
Author Correction: SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo.
Fukuda H, Seyama K, Ito K, Ai T, Nojiri S, Hori S, Wakita M, Saito K, Shida Y, Nagura R, Hasegawa M, Kanemoto C, Tokuhara M, Okajima K, Yoshikawa Y, Katsuta N, Yamamoto T, Idei M, Horiuchi Y, Yamatani K, Misawa S, Naito T, Miida T, Sato H, Hattori N, Tabe Y, Takahashi K. Fukuda H, et al. Among authors: wakita m. Sci Rep. 2021 Aug 2;11(1):16042. doi: 10.1038/s41598-021-95498-2. Sci Rep. 2021. PMID: 34341466 Free PMC article. No abstract available.
267 results